Essential Screening Services for Early Drug Evaluation

Ideal for biotech startups and early-stage research, CDT-OncoCore™ provides quick and reliable results for compound efficacy testing using 3D culture models.

What’s Included:

• IRB-approved patient tumor tissues
• Annotated patient samples
• Tumor/immune cell composition profiling
• Cytotoxicity assays
• Dose-response curve analysis*
• Comprehensive report & analysis

🕒 Turnaround: 5–10 days per sample*